MedCity News June 21, 2022
Frank Vinluan

Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.

Human Longevity, Inc., (HLI), a company aiming to use genomic insights to help people live longer, has found a way to extend its corporate life. The firm has reached a merger deal that will take the company public and infuse it with $345 million to bring its life-extending approach to more users in the U.S. and around the world.

San Diego-based...

Today's Sponsors

H1
ZeOmega
Holon

Today's Sponsors

Institute for Healthcare Improvement
Crossover Health

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma / Biotech, Precision Medicine, Trends
Analysis: Amazon-One Medical deal puts $4B spotlight on primary care convenience, but doesn’t threaten health systems
Amazon to acquire One Medical for $3.9 billion in a bold bet on primary care
Optum deal brings 2022 acquisition spending to nearly $8B
What Amazon’s $3.9B Acquisition of One Medical Means for Behavioral Health
Why Amazon's three biggest deals ever were for a grocery chain, movie studio, and health care provider